https://www.reuters.com/business/healthcare-pharmaceuticals/mesoblast-soars-us-fdas-nod-review-lead-drug-candidate-2023-03-08/#:~:text=The%20brokerage%20said%20it%20expects,%241.140%20earlier%20in%20the%20session.
Brokerage Jefferies said it expects "significant" U.S. sales of the drug (nah, therapy) in fiscal 2024.
PS: I will be adding on any pull backs.
This post is not to be construed as investment advice because it is not meant to be.
- Forums
- ASX - By Stock
- MSB
- Significant sales in fiscal 2024
Significant sales in fiscal 2024
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.127B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59782 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 26617 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59782 | 0.990 |
1 | 10000 | 0.980 |
1 | 20000 | 0.975 |
19 | 191088 | 0.970 |
6 | 94319 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 26617 | 2 |
1.000 | 127185 | 8 |
1.005 | 61027 | 3 |
1.010 | 5000 | 2 |
1.015 | 7142 | 3 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |